SARS-CoV-2_S1

Published: 24 October 2022| Version 1 | DOI: 10.17632/ch52rydwjh.1
Contributor:
Kazuhiro Kondo

Description

SARS-CoV-2 S1 protein causes brain inflammation by reducing intracerebral acetylcholine production

Files

Institutions

Tokyo Jikeikai Ika Daigaku

Categories

Depression, Acetylcholine, Inflammation, Encephalopathy, Fatigue (Symptom), Nicotinic Acetylcholine Receptor Agonist, Cholinergic Agent, COVID-19, Postcovid Syndrome

Licence